Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02142738 |
|---|---|
| Brief Title: | Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024) |
| First Submitted : | May 16, 2014 |
| First Submitted that Met QC Criteria : | May 16, 2014 |
| First Posted : | May 20, 2014 (Estimate) |
| Results First Submitted : | April 14, 2017 |
| Results First Submitted that Met QC Criteria : | June 8, 2017 |
| Results First Posted : | July 7, 2017 |
| Last Update Submitted that Met QC Criteria : | May 17, 2022 |
| Last Update Posted : | June 13, 2022 |